Kobayashi Yoshihiko, Kawaoi Akira, Katoh Ryohei
Fuji Biomedix Co., Ltd. Kobuchizawa Laboratories 10221, Kobuchizawa-cho, Kitakoma-gun, Yamanashi-ken, 408-0044, Japan.
Virchows Arch. 2002 Sep;441(3):289-95. doi: 10.1007/s00428-002-0608-y. Epub 2002 May 15.
To clarify the role of ras gene mutation in thyroid tumorigenesis, DNAs extracted from various rat thyroid lesions induced by di-isopropanolnitrosamine (DIPN) administration were analyzed using the microdissection-polymerase chain reaction-direct sequence (MD-PCR-DS) method. The MD-PCR-DS method revealed that K- ras gene mutation (G-A transition at codon 12) was frequently detected in nodular lesions (incidence of mutation 75%) and absent in diffuse hyperplastic and pre-nodular lesions. Although the incidence of mutation in nodular lesions was not correlated with the histological type (type 2A 76%; type 2B 84%; and type 3 71%) or treatment period (15 weeks 84% and 30 weeks 71%), it was correlated with the administration method (single injection 55% and serial injection 91%). In conclusion, K- ras mutation plays an important role in DIPN-induced rat thyroid tumorigenesis, possibly regarded as an early event in the tumorigenic process.
为阐明ras基因突变在甲状腺肿瘤发生中的作用,采用显微切割-聚合酶链反应-直接测序(MD-PCR-DS)方法,对经二异丙基亚硝胺(DIPN)处理诱导产生的各种大鼠甲状腺病变组织提取的DNA进行分析。MD-PCR-DS方法显示,在结节性病变中经常检测到K-ras基因突变(密码子12处G-A转换)(突变发生率为75%),而在弥漫性增生性病变和结节前期病变中未检测到。虽然结节性病变中的突变发生率与组织学类型(2A型76%;2B型84%;3型71%)或处理时间(15周84%,30周71%)无关,但与给药方式有关(单次注射55%,连续注射91%)。总之,K-ras突变在DIPN诱导的大鼠甲状腺肿瘤发生中起重要作用,可能被视为肿瘤发生过程中的早期事件。